Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Blood Advances
|
January 28, 2020
BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines
Sarah T Diepstraten, Catherine Chang, Lin Tai, et al.
The Laryngoscope
|
April 24, 2016
Reliability of office-based narrow-band imaging-guided flexible laryngoscopic tissue samplings
Catherine Chang, Wan-Ni Lin, Li-Jen Hsin, et al.
Journal of Psychiatric Practice
|
July 7, 2022
A Retrospective Study of the Adjunctive Use of Gabapentin With Benzodiazepines for the Treatment of Benzodiazepine Withdrawal
Edison Leung, Daniel H Ngo, Joe A Espinoza, et al.
JAMIA Open
|
March 9, 2026
Establishing the Digital Health Equity & Literacy Program (D-HELP): a student-led initiative to address digital health literacy gaps among emergency department patients at rush
Qianyi Pu, Ryan Guidi, Tejas C Sekhar, et al.
Cell Death and Differentiation
|
September 30, 2017
Coordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells
Leah Fitzsimmons, Andrew J Boyce, Wenbin Wei, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 16, 2018
Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC
Bradley G Ackerson, Betty C Tong, Julian C Hong, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 30, 2020
One-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia
Luyao Xia, Lei Liu, Xiaohong Hong, et al.
Blood Advances
|
October 5, 2020
BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphoma
Nenad Sejic, Lindsay C George, Rosemary J Tierney, et al.
Genes & Development
|
October 28, 2018
Mutant TRP53 exerts a target gene-selective dominant-negative effect to drive tumor development
Brandon J Aubrey, Ana Janic, Yunshun Chen, et al.
Cell Death & Disease
|
August 26, 2016
MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL
Ingela B Vikström, Anne Slomp, Emma M Carrington, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Blood Advances
|
January 28, 2020
BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines
Sarah T Diepstraten, Catherine Chang, Lin Tai, et al.
The Laryngoscope
|
April 24, 2016
Reliability of office-based narrow-band imaging-guided flexible laryngoscopic tissue samplings
Catherine Chang, Wan-Ni Lin, Li-Jen Hsin, et al.
Journal of Psychiatric Practice
|
July 7, 2022
A Retrospective Study of the Adjunctive Use of Gabapentin With Benzodiazepines for the Treatment of Benzodiazepine Withdrawal
Edison Leung, Daniel H Ngo, Joe A Espinoza, et al.
JAMIA Open
|
March 9, 2026
Establishing the Digital Health Equity & Literacy Program (D-HELP): a student-led initiative to address digital health literacy gaps among emergency department patients at rush
Qianyi Pu, Ryan Guidi, Tejas C Sekhar, et al.
Cell Death and Differentiation
|
September 30, 2017
Coordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells
Leah Fitzsimmons, Andrew J Boyce, Wenbin Wei, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 16, 2018
Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC
Bradley G Ackerson, Betty C Tong, Julian C Hong, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 30, 2020
One-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia
Luyao Xia, Lei Liu, Xiaohong Hong, et al.
Blood Advances
|
October 5, 2020
BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphoma
Nenad Sejic, Lindsay C George, Rosemary J Tierney, et al.
Genes & Development
|
October 28, 2018
Mutant TRP53 exerts a target gene-selective dominant-negative effect to drive tumor development
Brandon J Aubrey, Ana Janic, Yunshun Chen, et al.
Cell Death & Disease
|
August 26, 2016
MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL
Ingela B Vikström, Anne Slomp, Emma M Carrington, et al.
Page
of 6